Resources

Supplements of vitamin E may counteract complications in type-2 diabetics linked to an increased risk of heart disease.

Yet another diabetes drug has come under fire, after it was revealed last week that Byetta, manufactured and distributed by Eli Lilly and Amylin Pharmaceuticals, could be linked to acute pancreatitis in some patients.

Obesity increases the risk of developing diabetes, but nobody knows the details of why this is the case. Researchers at the Sahlgrenska Academy in Sweden have now identified a protein that may play a role in increasing the risk.

With an eye on curing diabetes, scientists at Washington University School of Medicine in St. Louis have successfully transplanted embryonic pig pancreatic cells destined to produce insulin into diabetic macaque monkeys — all without the need for risky immune suppression drugs that prevent rejection.

Scientists report new evidence linking insulin to a disorder of the brain: when the brain prevents the hormone from acting properly, the ensuing chemical imbalance may help trigger Alzheimer’s disease.

Creatinine screening needed in addition to albuminuria testing.

The Department of Veterans Affairs has decided to severely limit the use of Avandia, the once-popular drug for Type 2 diabetes, delivering another blow to the product’s maker, GlaxoSmithKline.

The FDA warned healthcare professionals that sudden loss of hearing has been reported in patients taking phosphodiesterase 5 (PDE-5) inhibitors.

Merck & Co. added warnings to its diabetes pill Januvia after some patients developed allergic conditions, including a rare, severe skin disorder.

Aspirin does not prevent heart attack for women to the same extent that it does for men, researchers affirmed.